We are pleased to share a copy of Nevada Governor Steve Sisolak’s proclamation declaring May as ME/CFS Awareness Month. We are deeply grateful to our state leaders and our Governor for their outstanding commitment to those who are impacted by complex neuroimmune diseases.
WPI has continued to invest its resources into two key areas of concern: accelerating treatment discovery and enhancing relevant education for physicians. To address these critical issues, WPI has created a medical support program in Reno and developed educational materials that are delivered through traditional and online methods.
WPI’s medical program provides space, equipment, and salary support for Dr. Kenny De Meirleir, WPI’s Medical Director. Dr. De Meirleir is an independent practicing physician who is internationally recognized as an ME/CFS expert. He is expanding his impact within Nevada and around the world through his clinical research studies conducted in collaboration with University of Nevada research scientists. Collaborations such as these are critical to the successful discovery of mechanisms of disease and/or biomarkers.
Biomarkers are not only vital to understanding disease processes, they are also key to identifying specific diseases for the purpose of treatment. Dr. De Meirleir’s most recent publication, Evaluation of Four Clinical Laboratory Parameters for the Diagnosis of Myalgic Encephalomyelitis, moves this important goal forward by identifying clinical tests that can aid in the diagnosis and treatment of ME/CFS.
Continuing education of medical doctors and patients in the diagnosis and treatment of neuroimmune diseases is another urgent need in this community. To address the significant lack of medical education overseas, Dr. De Meirleir created several European medical seminars based upon his extensive experience and knowledge. WPI has entered into discussions with the Bateman Horne Center of Utah about future collaborations in an effort to expand similar educational programs within the United States. We hope that by working together we can create greater progress for the benefit of the entire neuroimmune disease community.
We invite you to watch for exciting news updates as WPI moves forward!